Cisplatin primes murine peritoneal macrophages for enhanced expression of nitric oxide, proinflammatory cytokines, TLRs, transcription factors and activation of MAP kinases upon co-incubation with L929 cells
Authors:
- Ajit SodhiASAjit Sodhi
- Anju ShrivastavaASAnju Shrivastava
- 1 March 2009
- journal article
- Published by Elsevier in Immunobiology
- Vol. 214 (3) , 197-209
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Interaction between cisplatin treated murine peritoneal macrophages and L929 cells: Involvement of adhesion molecules, cytoskeletons, upregulation of Ca2+ and nitric oxide dependent cytotoxicityMolecular Immunology, 2007
- Activation of Kupffer cells inhibits tumor growth in a murine model systemInternational Journal of Cancer, 2002
- Activation of cytokine production, tumoricidal properties, and tyrosine phosphorylation of MAPKs in human monocytes by a new synthetic lipopeptide, JBT3002Journal of Leukocyte Biology, 1998
- Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharideEuropean Journal of Immunology, 1994
- Tumour-cell-induced production of tumour necrosis factor by monocytes of gastric cancer patients receiving BCG immunotherapyCancer Immunology, Immunotherapy, 1993
- Macrophage tumoricidal mechanismsResearch in Immunology, 1993
- Activation of tumoricidal properties in macrophages by lipopolysaccharide requires protein-tyrosine kinase activityJournal of Leukocyte Biology, 1993
- The origin and function of tumor-associated macrophagesImmunology Today, 1992
- Tumoricidal activity and cytokine secretion by tumor‐infiltrating macrophagesInternational Journal of Cancer, 1991
- Molecular mechanisms in tumor-cell killing by activated macrophagesImmunology Today, 1983